Tandem Diabetes Care, Inc. TNDM

Full chart Compare
Set alert

Price alert · TNDM

All alert types
17.65 USD -1.02 (-5.46%)

At closeNov 3, 2026, 5:17 PM EST

17.65 0.00 0.00%

After hours · Nov 3, 5:17 PM ET

17.62 Day range 18.67
12.26 52-week range 29.65
YTD
-19.70%
1 year
+22.91%
Market cap
1.23B
Revenue (ttm)
1.04B
Profit margin
-6.08%
EPS (ttm)
-0.91
Shares out
69.58M
Forward P/E
111.03
YTD return
-19.70%
1-year return
+22.91%
Volume
2.57M
Avg volume
2.13M
Open
18.67
Previous close
18.67
Day's range
17.62 – 18.67
52-week range
12.26 – 29.65
Beta
1.59
Analysts
Buy
Price target
27.76 (+57.3%)
Earnings date
Nov 5, 2026

2Y -15.20 (-46.27%)

102030Jan 25Jun 25Nov 25Mar 26Aug 2617.65

Key statistics

Enterprise value
1.58B
PEG ratio
0.00
Price / sales
1.18
Price / book
9.41
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
5.80%
Free cash flow
-43.95M
Total cash
456.00M
Total debt
739.25M
Return on equity
-48.03%
Short % of float
29.04%
50-day average
17.95
200-day average
18.92

Financials — quick view

All financials
TNDM Revenue — quarterly 254.56M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TNDM Net income — quarterly -21.17M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TNDM EPS — quarterly -0.31
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

TNDM recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 2026-0.24533———
Aug 6, 2026Jun 30, 2026-0.32074-0.31+0.01+3.35%
May 7, 2026Mar 31, 2026-0.46-0.30+0.16+34.78%
Feb 19, 2026Dec 31, 2025-0.05-0.01+0.04+80.00%
Nov 6, 2025Sep 30, 2025-0.31-0.310.000.00%
Aug 6, 2025Jun 30, 2025-0.40-0.48-0.08-20.00%

Upgrades / downgrades

TNDM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 30, 2026CitigroupmainNeutralNeutral
Sep 24, 2026Truist SecuritiesmainBuyBuy
Aug 21, 2026William Blairinit—Outperform
Aug 7, 2026CitigroupmainNeutralNeutral
Aug 7, 2026RBC CapitalmainOutperformOutperform

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on TNDM — it syncs with the Stock Master app.

Insider holders

TNDM insider holders
InsiderRelationLatest transactionDateShares held
ALLEN DICK PRetiredConversion of Exercise of derivative securityMay 20, 202650,903
BLICKENSTAFF KIM DDirectorSaleNov 20, 20240
CARPENTER RICKChief Technology OfficerConversion of Exercise of derivative securityAug 13, 202632,148
GASSER ELIZABETH ANNEOfficerConversion of Exercise of derivative securityAug 13, 202634,505
HANSEN SHANNON MARIEOfficerConversion of Exercise of derivative securityAug 13, 202633,585
MORRISON SUSAN MOfficerConversion of Exercise of derivative securityAug 13, 202652,788

Institution ownership

TNDM institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.65%11,583,125204.44MJun 29, 2026
Sessa Capital IM, L.P.7.33%5,100,00090.01MJun 29, 2026
Vanguard Portfolio Management LLC6.18%4,299,66775.89MJun 29, 2026
First Light Asset Management, LLC4.86%3,383,55359.72MJun 29, 2026
Vanguard Capital Management LLC4.45%3,096,53654.65MJun 29, 2026
State Street Corporation4.10%2,851,64650.33MJun 29, 2026

Fund ownership

TNDM fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%4,140,27873.08MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.14%2,186,91838.60MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.59%1,803,94731.84MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.26%1,570,01927.71MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.30%901,46715.91MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.13%788,50913.92MJun 29, 2026